Live Breaking News & Updates on தடுப்பூசி மதிப்பீடு|Page 4

Stay updated with breaking news from தடுப்பூசி மதிப்பீடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DOST to wait for 'acceptable efficacy, safety data' before expanding vaccine trials to minors – Manila Bulletin


Published June 10, 2021, 11:01 PM
The Department of Science and Technology (DOST) on Thursday, June 10, maintained that only individuals aged 18 years old and above are allowed to participate in the vaccine trials in the country – noting that getting preliminary data is very crucial before expanding it to the younger age group.
(ALI VICOY / MANILA BULLETIN)
Issuing an official statement, DOST Undersecretary for Research and Development (R&D) Rowena Cristina l. Guevara said that to date, individuals who are 17 years old and below are not yet allowed to participate in any coronavirus disease (COVID-19) vaccine trials in the Philippines for several reasons.
“There are two main reasons why the Task Group on Vaccine Evaluation (TG VES) and Selection has so far not included children aged 17 and under in vaccine trials,” Guevara said in Filipino. ....

United States , United Kingdom , Undersecretary For Research , Task Group On Vaccine Evaluation , Drug Administration , Development Rd Rowena Cristinal Guevara , Department Of Health , Department Of Science , Rowena Cristina , Task Group , Vaccine Evaluation , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பணி குழு ஆன் தடுப்பூசி மதிப்பீடு , துறை ஆஃப் ஆரோக்கியம் , துறை ஆஃப் அறிவியல் , ரொவீந கிறிஸ்டினா , பணி குழு , தடுப்பூசி மதிப்பீடு ,